建立Esomeprazole在具有CYP2C19基因多型體之胃食道逆流疾病治療的最佳給藥療程與其控釋劑型之開發

Other Title
Development of Optimal Dose Regimens of Esomeprazole for Gerd with Influence of CYP2C19 Polymorphism
Type
report
Date Issued
1996
Author(s)
何秀娥;張君照
Subjects
藥學系
計畫報告
URI
File(s)
No Thumbnail Available
Name

attachment.pdf

Size

0 B

Format

Adobe PDF

Checksum

(MD5):d41d8cd98f00b204e9800998ecf8427e

Loading...
Thumbnail Image
Name

attachment2.pdf

Size

172.63 KB

Format

Adobe PDF

Checksum

(MD5):1da8d4ce4da15dcc557e97f0666271e8

Copyright Notice

● The digital content on this platform is part of the Taipei Medical University Institutional Repository, featuring various academic works and outputs from the institution. It offers free access to academic research and public education for non-commercial use.

● Please use the content appropriately and within legal boundaries to respect copyright owners' rights. For commercial use, please obtain prior authorization from the copyright owner. Users must not use TMUIR for any illegal purposes.

● By utilising the platform, users are deemed to have fully accepted and understood all the regulations set out in this statement, relevant laws of the Republic of China, all international internet regulations, and usage conventions.

● TMUIR is committed to protecting the interests of copyright owners. If you believe that any material on this website infringes copyright, please contact our staff at libirtmu@gmail.com, and we will remove the work from the repository.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science